These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23660331)

  • 1. Six-monthly diabetes monitoring of well-controlled patients: experiences of primary care providers.
    Wermeling PR; Janssen J; Gorter KJ; Beulens JW; Rutten GE
    Prim Care Diabetes; 2013 Oct; 7(3):187-91. PubMed ID: 23660331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and cost-effectiveness of 3-monthly versus 6-monthly monitoring of well-controlled type 2 diabetes patients: a pragmatic randomised controlled patient-preference equivalence trial in primary care (EFFIMODI study).
    Wermeling PR; Gorter KJ; Stellato RK; de Wit GA; Beulens JW; Rutten GE
    Diabetes Obes Metab; 2014 Sep; 16(9):841-9. PubMed ID: 24635880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards a more efficient diabetes control in primary care: six-monthly monitoring compared with three-monthly monitoring in type 2 diabetes - The EFFIMODI trial. Design of a randomised controlled patient-preference equivalence trial in primary care.
    Wermeling PR; van den Donk M; Gorter KJ; Ardine de Wit G; van der Graaf Y; Rutten GE
    BMC Fam Pract; 2010 May; 11():35. PubMed ID: 20459820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Satisfaction of well-controlled type 2 diabetes patients with three-monthly and six-monthly monitoring.
    Wermeling PR; Janssen J; Gorter KJ; Beulens JW; Rutten GE
    BMC Fam Pract; 2013 Jul; 14():107. PubMed ID: 23899039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of supported telemetric monitoring in people with type 2 diabetes: study protocol for a randomised controlled trial.
    Wild S; Hanley J; Lewis S; McKnight J; McCloughan L; Padfield P; Paterson M; Pinnock H; McKinstry B
    Trials; 2013 Jul; 14():198. PubMed ID: 23829417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How are we diagnosing cardiometabolic risk in primary care settings?
    Gohdes D; Amundson H; Oser CS; Helgerson SD; Harwell TS
    Prim Care Diabetes; 2009 Feb; 3(1):29-35. PubMed ID: 19155195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes education and care in a developing country: observations from Karachi, Pakistan.
    Sheikh MA; Hakeem R; Asar F; Shaikh AH
    Prim Care Diabetes; 2015 Feb; 9(1):48-53. PubMed ID: 24938175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal type 2 diabetes mellitus management: the randomised controlled OPTIMISE benchmarking study: baseline results from six European countries.
    Hermans MP; Brotons C; Elisaf M; Michel G; Muls E; Nobels F;
    Eur J Prev Cardiol; 2013 Dec; 20(6):1095-105. PubMed ID: 22605788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of an mHealth-enabled hierarchical diabetes management intervention in primary care in China (ROADMAP): A cluster randomized trial.
    Jia W; Zhang P; Zhu D; Duolikun N; Li H; Bao Y; Li X;
    PLoS Med; 2021 Sep; 18(9):e1003754. PubMed ID: 34547030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in HbA1c using professional flash glucose monitoring in insulin-treated type 2 diabetes patients managed in primary and secondary care settings: A pilot, multicentre, randomised controlled trial.
    Ajjan RA; Jackson N; Thomson SA
    Diab Vasc Dis Res; 2019 Jul; 16(4):385-395. PubMed ID: 31271312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding drug preferences, different perspectives.
    Mol PG; Arnardottir AH; Straus SM; de Graeff PA; Haaijer-Ruskamp FM; Quik EH; Krabbe PF; Denig P
    Br J Clin Pharmacol; 2015 Jun; 79(6):978-87. PubMed ID: 25469876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of poorly controlled Type 2 diabetes patients in Swiss primary care.
    Frei A; Herzog S; Woitzek K; Held U; Senn O; Rosemann T; Chmiel C
    Cardiovasc Diabetol; 2012 Jun; 11():70. PubMed ID: 22704274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does good clinical practice at the primary care improve the outcome care for diabetic patients? Gender differences.
    Bener A; Abdulmalik M; Al-Kazaz M; Sanya R; Buhmaid S; Al-Harthy M; Mohammad AG
    Prim Care Diabetes; 2012 Dec; 6(4):285-92. PubMed ID: 22622594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to national diabetes guidelines through monitoring quality indicators--A comparison of three types of care for the elderly with special emphasis on HbA1c.
    Neumark AS; Brudin L; Neumark T
    Prim Care Diabetes; 2015 Aug; 9(4):253-60. PubMed ID: 25865853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin therapy in type 2 diabetes is no longer a secondary care activity in the Netherlands.
    van Avendonk MJ; Gorter KJ; van den Donk M; Rutten GE
    Prim Care Diabetes; 2009 Feb; 3(1):23-8. PubMed ID: 19095513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dapagliflozin therapy for type 2 diabetes in primary care: Changes in HbA1c, weight and blood pressure over 2 years follow-up.
    Wilding J; Bailey C; Rigney U; Blak B; Kok M; Emmas C
    Prim Care Diabetes; 2017 Oct; 11(5):437-444. PubMed ID: 28583425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical coaching in primary care: Capable of improving control in patients with type 2 diabetes mellitus?
    González-Guajardo EE; Salinas-Martínez AM; Botello-García A; Mathiew-Quiros Á
    Prim Care Diabetes; 2016 Jun; 10(3):171-8. PubMed ID: 26615758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary care physician perspectives on basal insulin initiation and maintenance in patients with type 2 diabetes mellitus.
    Kalirai S; Stephenson J; Perez-Nieves M; Grabner M; Hadjiyianni I; Geremakis C; Pollom RD; Reed B; Fisher L
    Prim Care Diabetes; 2018 Apr; 12(2):155-162. PubMed ID: 29100717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health technologies for monitoring and managing diabetes: a systematic review.
    Russell-Minda E; Jutai J; Speechley M; Bradley K; Chudyk A; Petrella R
    J Diabetes Sci Technol; 2009 Nov; 3(6):1460-71. PubMed ID: 20144402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact and duration effect of telemonitoring on ΗbA1c, BMI and cost in insulin-treated Diabetes Mellitus patients with inadequate glycemic control: A randomized controlled study.
    Fountoulakis S; Papanastasiou L; Gryparis A; Markou A; Piaditis G
    Hormones (Athens); 2015; 14(4):632-43. PubMed ID: 26188234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.